Wasik M A, Morimoto C
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA.
J Immunol. 1990 May 1;144(9):3334-40.
We report that the subsets of CD4+ T cells characterized by differential expression of CD45RA (2H4) Ag showed significant differences in proliferative response to immobilized anti-CD3 antibody (Ab) and cytokines: IL-1, IL-2, IL-4, and IL-6. Most strikingly, CD4+/45RA+ but not CD4+/45RA- T cells responded to anti-CD3 Ab and IL-4. Similar difference in response to IL-4 occurred when the subsets were stimulated by two "alternative" T cell activation pathways via CD2 and GD3 Ag. The response of CD4+/45RA+ cells to anti-CD3 Ab and IL-4 was enhanced by the two monokines: IL-1 and IL-6. Further differences between the subsets included the preferential response of the CD4+/45RA+ cells to enhancing effect of IL-6 on proliferation mediated by the anti-CD3 Ab and IL-2. In contrast to IL-6, IL-1 was unable to increase this proliferation significantly. In turn, the CD4+/45RA- cells responded preferentially to a weak stimulation mediated by anti-CD3 Ab either alone, or together with IL-1 and IL-6. Existence of these significant differences in the response of CD4+ T cell subsets costimulatory effects of the cytokines, suggests that the in vivo events resulting in an accumulation of the cytokines in particular combinations may lead to selective activation of one of the CD4+ T cell subsets during the immune response.
我们报告,以CD45RA(2H4)抗原差异表达为特征的CD4+T细胞亚群,在对固定化抗CD3抗体(Ab)和细胞因子(IL-1、IL-2、IL-4和IL-6)的增殖反应中表现出显著差异。最显著的是,CD4+/45RA+而非CD4+/45RA-T细胞对抗CD3抗体和IL-4有反应。当通过CD2和GD3抗原经两条“替代性”T细胞激活途径刺激这些亚群时,对IL-4的反应也存在类似差异。IL-1和IL-6这两种单核因子增强了CD4+/45RA+细胞对抗CD3抗体和IL-4的反应。这些亚群之间的进一步差异包括,CD4+/45RA+细胞优先对IL-6增强抗CD3抗体和IL-2介导的增殖的作用有反应。与IL-6相反,IL-1不能显著增加这种增殖。反过来,CD4+/45RA-细胞优先对单独由抗CD3抗体或与IL-1和IL-6共同介导的弱刺激有反应。CD4+T细胞亚群反应存在这些显著差异以及细胞因子的共刺激作用,表明体内导致细胞因子以特定组合积累的事件可能在免疫反应期间导致CD4+T细胞亚群之一的选择性激活。